This site is intended for US residents 18 years of age and older

INDICATIONS AND USAGE

SPRYCEL® (dasatinib) is a prescription medicine used to treat:

  • adults with newly diagnosed Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase
  • adults with Ph+ CML who no longer benefit from, or did not tolerate, other treatment, including imatinib
  • adults with Ph+ acute lymphoblastic leukemia (Ph+ ALL) who no longer benefit from, or did not tolerate, other treatment
  • children 1 year of age and older with Ph+ CML in chronic phase
  • children 1 year of age and older with newly diagnosed Ph+ ALL in combination with chemotherapy

It is not known if SPRYCEL is safe and effective in children under 1 year of age.

Understanding Ph+ CML

What happens in Ph+ cml? video

BECOME AN INSPIRATION

“My health care team talked about what to expect and different milestones I could obtain.”
– Sam, SPRYCEL patient

Watch Sam’s Story
Sam, a SPRYCEL® (dasatinib) patient
Sam, a SPRYCEL® (dasatinib) patient
Back
to Top